SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device.
SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device that can rapidly detect pathogens in whole blood.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 21, 2022 | Seed | €5M | 1 | — | — | Detail |
Jan 12, 2021 | Grant | €2.40M | 1 | European Innovation Council | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | — | Seed |